Evidence map›Paper›PMID 22446478›Full record

ReviewNeuropharmacology2013

HCN and KV7 (M-) channels as targets for epilepsy treatment.

Mala M Shah, Zhuo Huang, Katiuscia Martinello

Abstract readReview
In one paragraph

Review in Neuropharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. ICA-27243 improves neuromuscular function and preserves motoneurons in the transgenic SOD1Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  3. KCNQ Channels Enable Reliable Presynaptic Spiking and Synaptic Transmission at High Frequency.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A Loss-of-FunctionFrontiers in molecular neuroscience · 2018
    Article
  10. Article
  11. Article
  12. Review
  13. Dysfunctional HCN ion channels in neurological diseases.Frontiers in cellular neuroscience · 2015
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. TRIP8b-independent trafficking and plasticity of adult cortical presynaptic HCN1 channels.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mala M ShahDepartment of Pharmacology, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, United Kingdom. mala.shah@pharmacy.ac.uk
Zhuo Huang
Katiuscia Martinello
University of London · GBMedway School of Pharmacy · GB

Funding

European Research Council 260725Medical Research Council G0700369Wellcome Trust 087363Wellcome Trust WT087363MA
6 · The paper itself

Abstract

Voltage-gated ion channels are important determinants of cellular excitability. The Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) and KV7 (M-) channels are voltage-gated ion channels. Both channels are activated at sub-threshold potentials and have biophysical properties that mirror each other. KV7 channels inhibit neuronal excitability. Thus, mutations in KV7 channels that are associated with Benign Familial Neonatal Convulsions (BFNC) are likely to be epileptogenic. Mutations in HCN channels have also been associated with idiopathic epilepsies such as GEFS+. In addition, HCN channel expression and function are modulated during symptomatic epilepsies such as temporal lobe epilepsy. It is, though, unclear as to whether the changes in HCN channel expression and function associated with the various forms of epilepsy promote epileptogenesis or are adaptive. In this review, we discuss this as well as the potential for KV7 and HCN channels as drug targets for the treatment of epilepsy. This article is part of the Special Issue entitled 'New Targets and Approaches to the Treatment of Epilepsy'.

Indexed as

AnimalsAnticonvulsantsBiophysicsCyclic Nucleotide-Gated Cation ChannelsEpilepsyHumansHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsKCNQ Potassium ChannelsMutationPotassium ChannelsSeizuresSubcellular FractionsAnticonvulsantsCyclic Nucleotide-Gated Cation ChannelsHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsKCNQ Potassium ChannelsPotassium Channels

Identifiers

PMID22446478
PMCPMC4104618
OpenAlexW2161628727

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.